TY - JOUR
T1 - Whole-body MRI in oncology
T2 - acquisition protocols, current guidelines, and beyond
AU - Zugni, Fabio
AU - Mariani, Leonardo
AU - Lambregts, Doenja M J
AU - Maggioni, Roberta
AU - Summers, Paul E
AU - Granata, Vincenza
AU - Pecchi, Annarita
AU - Di Costanzo, Giuseppe
AU - De Muzio, Federica
AU - Cardobi, Nicolò
AU - Giovagnoni, Andrea
AU - Petralia, Giuseppe
PY - 2024/9
Y1 - 2024/9
N2 - Acknowledging the increasing use of whole-body magnetic resonance imaging (WB-MRI) in the oncological setting, we conducted a narrative review focusing on practical aspects of the examination and providing a synthesis of various acquisition protocols described in the literature. Firstly, we addressed the topic of patient preparation, emphasizing methods to enhance examination acceptance. This included strategies for reducing anxiety and patient distress, improving staff-patient interactions, and increasing overall patient comfort. Secondly, we analysed WB-MRI acquisition protocols recommended in existing imaging guidelines, such as MET-RADS-P, MY-RADS, and ONCO-RADS, and provided an overview of acquisition protocols reported in the literature regarding other expanding applications of WB-MRI in oncology, in patients with breast cancer, ovarian cancer, melanoma, colorectal and lung cancer, lymphoma, and cancers of unknown primary. Finally, we suggested possible acquisition parameters for whole-body images across MR systems from three different vendors.
AB - Acknowledging the increasing use of whole-body magnetic resonance imaging (WB-MRI) in the oncological setting, we conducted a narrative review focusing on practical aspects of the examination and providing a synthesis of various acquisition protocols described in the literature. Firstly, we addressed the topic of patient preparation, emphasizing methods to enhance examination acceptance. This included strategies for reducing anxiety and patient distress, improving staff-patient interactions, and increasing overall patient comfort. Secondly, we analysed WB-MRI acquisition protocols recommended in existing imaging guidelines, such as MET-RADS-P, MY-RADS, and ONCO-RADS, and provided an overview of acquisition protocols reported in the literature regarding other expanding applications of WB-MRI in oncology, in patients with breast cancer, ovarian cancer, melanoma, colorectal and lung cancer, lymphoma, and cancers of unknown primary. Finally, we suggested possible acquisition parameters for whole-body images across MR systems from three different vendors.
KW - Diffusion magnetic resonance imaging
KW - Li-Fraumeni syndrome
KW - Melanoma
KW - Multiple myeloma
KW - Prostate cancer
KW - Whole body imaging
U2 - 10.1007/s11547-024-01851-6
DO - 10.1007/s11547-024-01851-6
M3 - (Systematic) Review article
SN - 0033-8362
VL - 129
SP - 1352
EP - 1368
JO - Radiologia medica
JF - Radiologia medica
IS - 9
ER -